000			01976cam a2200313 i 4500
999			_c6592 _d6592
001			21393551
003			OSt
005			20210930102626.0
008			200111s2019 nyu b 001 0 eng
020			_a0919115772
040			_aBUL _beng _cBUL _erda _dBUL
082	0	0	_a615.5 _223 _bTHE
245	0	0	_aTherapeutic Choices / _cEditor, Jean Gray
250			_a2nd edition
264		1	_aCanada : _bCanadian Pharmacists Association , _c1998
300			_axv, 886 p. ; _c23 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
500			_aContents Psychiatric Disorders Neurologic Disorders Eye Disorders Cardiovascular Disorders Respiratory Disorders Gastrointestinal Disorder Genitoiurinary Disorders Musculoskeletal Disorders Skin Disorders Endocrine Disorders BLood Disorders Antineoplastics Drugs in Pregnancy and Lactation Fluid and Electrolyte Disorders Infectious Diseases Minerals and Vitamins Symptom control
504			_aIncludes bibliographical references and index.
520			_a"Racecadotril represents, so far, the unique drug acting on one of the main pathophysiological mechanisms underlying acute diarrhea. In this book some experts discussed the main international diarrheal guidelines in children and adults even analyzing the health costs of the disease. Other authors have thoroughly addressed the etiopathological mechanisms underlying acute diarrhea and some others have fully analyzed the clinical studies on Racecadotril present in the literature both in children and adults"-- _cProvided by publisher.
650		0	_aTherapeutics- Handbook, Manual etc
650		0	_aTherapeutics
700			_aGray, Jean
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBO _e2nd edition _h615.5 _i1 _kTHE _m615.5 THE